PTC Therapeutics PTCT Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's finance lease liability, current?
- PTC Therapeutics (PTCT) reported finance lease liability, current of $6M in Q1 2026.
- How has PTC Therapeutics's finance lease liability, current changed year-over-year?
- PTC Therapeutics's finance lease liability, current increased by 18.9% year-over-year, from $5.05M to $6M.
- What is the long-term trend for PTC Therapeutics's finance lease liability, current?
- Over 5 years (2020 to 2025), PTC Therapeutics's finance lease liability, current has grown at a 18.6% compound annual growth rate (CAGR), from $1.28M to $3M.
- What does finance lease liability, current mean?
- Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.